By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.
The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR
test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution
during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients
presented to our hospital during the pandemic will be involved in our study. The primary
outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..
Diagnostic Test: PCR, lung ultrasound
PCR for Covid-19
Inclusion Criteria:
- First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs
between March 15, 2020 and June 1, 2020.
Exclusion Criteria:
- The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic
- Preeclamptic patient without a Covid-19 PCR test result
- Pregnant women who does not want to participate in study or does not want their
personal informations to be shared
- Pregnant women less than 18 years old and more than 40 years old are excluded
Zeynep Kamil Maternity and Childrens Training and Research Hospital
Istanbul, Turkey
Resul Karakus, MD, Principal Investigator
Zeynep Kamil Maternity and Childrens Hospital Training and Research Hospital